Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.

Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.

Plasmodium vivax is the world's most widely distributed malaria parasite and a potential cause of morbidity and mortality for approximately 2.85 billion people living mainly in Southeast Asia and Latin America. Despite this dramatic burden, very few vaccines have been assessed in humans. The cl...

Bibliográfalaš dieđut
Váldodahkkit:	Bauza, K, Malinauskas, T, Pfander, C, Anar, B, Jones, E, Billker, O, Hill, A, Reyes-Sandoval, A
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2014

Geahča maid

Characterization of merozoite-specific thrombospondin-related anonymous protein (MTRAP) in Plasmodium vivax and P. knowlesi parasites
Dahkki: Nguyen Sy Thau, et al.
Almmustuhtton: (2024-02-01)

Identification and characterization of the <it>Plasmodium vivax </it>thrombospondin-related apical merozoite protein
Dahkki: Villarreal-Gonzalez Silvana, et al.
Almmustuhtton: (2010-10-01)

Role of <it>Plasmodium falciparum </it>thrombospondin-related anonymous protein in host-cell interactions
Dahkki: Malhotra Pawan, et al.
Almmustuhtton: (2008-04-01)

Attempted isolation of the gene encoding the 21 Kd Plasmodium berghei ookinete transmission blocking antigen from Plasmodium yoelli and Plasmodium vivax
Dahkki: G. C. Barker, et al.
Almmustuhtton: (1994-01-01)

The alveolin IMC1h is required for normal ookinete and sporozoite motility behaviour and host colonisation in Plasmodium berghei.
Dahkki: Katrin Volkmann, et al.
Almmustuhtton: (2012-01-01)

Plasmodium vivax thrombospondin related adhesion protein: immunogenicity and protective efficacy in rodents and Aotus monkeys
Dahkki: Angélica Castellanos, et al.
Almmustuhtton: (2007-06-01)

Phase Ia clinical evaluation of the plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors
Dahkki: Sheehy, S, et al.
Almmustuhtton: (2011)

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
Dahkki: Sheehy, S, et al.
Almmustuhtton: (2011)

Azadirachtin disrupts formation of organised microtubule arrays during microgametogenesis of Plasmodium berghei.
Dahkki: Billker, O, et al.
Almmustuhtton: (2002)

Transmission-blocking compound candidates against Plasmodium vivax using P. berghei as an initial screening
Dahkki: Camila Fabbri, et al.
Almmustuhtton: (2021-02-01)

Plasmodium vivax merozoite-specific thrombospondin-related anonymous protein (PvMTRAP) interacts with human CD36, suggesting a novel ligand–receptor interaction for reticulocyte invasion
Dahkki: Thau Sy Nguyen, et al.
Almmustuhtton: (2023-11-01)

The dynamics of interactions between Plasmodium and the mosquito: a study of the infectivity of Plasmodium berghei and Plasmodium gallinaceum, and their transmission by Anopheles stephensi, Anopheles gambiae and Aedes aegypti.
Dahkki: Alavi, Y, et al.
Almmustuhtton: (2003)

Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.
Dahkki: Sheehy, S, et al.
Almmustuhtton: (2012)

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
Dahkki: Mensah, V, et al.
Almmustuhtton: (2016)

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
Dahkki: Victorine A Mensah, et al.
Almmustuhtton: (2016-01-01)

Maintenance of the Plasmodium berghei life cycle.
Dahkki: Sinden, R, et al.
Almmustuhtton: (2002)

Generation of gene targeting constructs for Plasmodium berghei by a PCR-based method amenable to high throughput applications.
Dahkki: Ecker, A, et al.
Almmustuhtton: (2006)

The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.
Dahkki: Ramjanee, S, et al.
Almmustuhtton: (2007)

Spatial variation in genetic diversity and natural selection on the thrombospondin-related adhesive protein locus of Plasmodium vivax (PvTRAP).
Dahkki: Rattiporn Kosuwin, et al.
Almmustuhtton: (2014-01-01)

Attacking Plasmodium vivax
Dahkki: Baird, J
Almmustuhtton: (2016)

Plasmodium vivax Malaria
Dahkki: Dhanpat K. Kochar, et al.
Almmustuhtton: (2005-01-01)

Malaric relapses due to Plasmodium Vivax Reinfección engógena por Plasmodium vivax
Dahkki: Cecilia Giraldo, et al.
Almmustuhtton: (1991-01-01)

Neddylation is essential for malaria transmission in Plasmodium berghei
Dahkki: Bandita Nayak, et al.
Almmustuhtton: (2024-04-01)

Differential Fractionation of Erythrocytes Infected by Plasmodium berghei
Dahkki: Bénédicte Gnangnon, et al.
Almmustuhtton: (2020-06-01)

Plasmodium berghei calcium-dependent protein kinase 3 is required for ookinete gliding motility and mosquito midgut invasion.
Dahkki: Siden-Kiamos, I, et al.
Almmustuhtton: (2006)

A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.
Dahkki: Dunachie, S, et al.
Almmustuhtton: (2006)

Genetic diversity of <it>Plasmodium vivax</it> and <it>Plasmodium falciparum</it> in Honduras
Dahkki: Lopez Ana, et al.
Almmustuhtton: (2012-11-01)

Evolutionary history of Plasmodium vivax and Plasmodium simium in the Americas
Dahkki: Virginie Rougeron, et al.
Almmustuhtton: (2022-05-01)

Correction: Spatial variation in genetic diversity and natural selection on the thrombospondin-related adhesive protein locus of Plasmodium vivax (PvTRAP).
Dahkki: Rattiporn Kosuwin, et al.
Almmustuhtton: (2018-01-01)

Protective Immunity Induced by Immunization with Baculovirus, Virus-like Particle, and Vaccinia Virus Expressing the AMA1 of <i>Plasmodium berghei</i>
Dahkki: Min-Ju Kim, et al.
Almmustuhtton: (2022-09-01)

A genetically modified Plasmodium berghei parasite as a surrogate for whole-sporozoite vaccination against P. vivax malaria
Dahkki: Diana Moita, et al.
Almmustuhtton: (2022-12-01)

Recombinant Vaccinia Virus Expressing <i>Plasmodium berghei</i> Apical Membrane Antigen 1 or Microneme Protein Enhances Protection against <i>P. berghei</i> Infection in Mice
Dahkki: Min-Ju Kim, et al.
Almmustuhtton: (2022-11-01)

Global epidemiology of Plasmodium vivax
Dahkki: Howes, R, et al.
Almmustuhtton: (2016)

Plasmodium vivax transmission in Africa
Dahkki: Howes, R, et al.
Almmustuhtton: (2015)

Global Epidemiology of Plasmodium vivax
Dahkki: Howes, R, et al.
Almmustuhtton: (2016)

The epidemiology of Plasmodium vivax. Preface.
Dahkki: Hay, S, et al.
Almmustuhtton: (2013)

Rosette formation by Plasmodium vivax.
Dahkki: Udomsanpetch, R, et al.
Almmustuhtton: (1995)

Plasmodium vivax susceptibility to ferroquine.
Dahkki: Leimanis, M, et al.
Almmustuhtton: (2010)

Neglect of Plasmodium vivax malaria.
Dahkki: Baird, J
Almmustuhtton: (2007)

The burden of Plasmodium vivax malaria
Dahkki: Battle, K
Almmustuhtton: (2015)